This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
September 2023 saw a wave of new pharmaceuticalmanufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceuticalmanufacturing, the addition of AI technologies introduce a paradigm shift. Figure 1 : adapted from Saha, G. Tuijin Jishu/Journal of Propulsion Technology, 44(3), 1384-1392.
Uncovering new frontiers in microbiology and EM In this Q&A, Laure Pomares Voisin, Quality Director, Catalent Biologics and Tony Cundell Principal Consultant, Microbiological Consulting, LLC discuss some of the key microbiology and environmental monitoring challenges and trends in pharmaceuticalmanufacturing today.
Granules India Limited- Walk-In Drive for Quality Control Department On 9th Jan’ 2023. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Drive for Quality Control Department On 9th Jan’ 2023 @ Granules India Limited @ Hyderabad.
Aurobindo Pharma-Walk-In Interviews for Freshers in Production/ Packing On 4th Jan’ 2023. APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Date : 4th Jan’ 2023. Aurobindo Pharma-Walk-In Interviews for Freshers in Production/ Packing On 4th Jan’ 2023.
Aurobindo Pharma-Walk-In Interviews for Quality Control On 4th Mar’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! Walk-In Interviews for Executive/ Sr.
At the beginning of this year, EPR reported on the potential blockbuster pharmaceutical drugs to watch in 2023. The year 2023 also brought much advancement in the Alzheimer’s space for the pharmaceutical industry. Since then, EPR has covered developments for several of the therapies highlighted in the report.
Aurobindo Pharma-Walk-In Interviews for Quality Control/ Production On 7th Jan’ 2023. APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Date : 7th Jan’ 2023. Aurobindo Pharma-Walk-In Interviews for Quality Control/ Production On 7th Jan’ 2023. Job Description.
APL Health Care (Aurobindo )-Walk-In Interviews for IPQA/ Microbiology On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8
Moreover, pharmaceuticalmanufacturing poses a huge detriment to the state of the planet’s ecosystem. Active pharmaceutical ingredients (APIs) are particularly impact intensive, soaking up a large quantity of resources in terms of heat, energy and water when being produced.
Aurobindo Pharma-Walk-In Interviews for Packing Department On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 TA/ Executive/ Sr.
Granules India Limited- Walk-In Interviews for Freshers On 7th Jan’ 2023. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Interviews for Freshers On 7th Jan’ 2023 @ Granules India Limited (Gagillapur-Hyderabad). Job Description.
Granules India Limited- Walk-In Drive for Freshers in Quality Control/ Production/ Warehouse On 16th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Drive for B.Sc / M.Sc/ B.Pharm/ B.Com/ B.A/
Aurobindo Pharma-Walk-In Interviews for Quality Control On 3rd Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8
Aurobindo Pharma-Walk-In Interviews for Production/ Quality Control/ Packing On 5th Mar’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Executive/ Technicians Job Location: Unit-XV, Visakhapatnam, A.P.
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8
Based on the new cost estimates, pharmaceuticalmanufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
Granules India Limited- Walk-In Interviews for Freshers & Experienced On 5th March 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Granules India Limited- Walk-In Interviews for Freshers & Experienced On 5th March 2023
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 7th Jan’ 2023. APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Area of Exposure: RM/ PM/ IP/ FP/ Stability/ GLP & Micro/ Manufacturing & Packing. Date : 7th Jan’ 2023.
The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceuticalmanufacturing and quality control.
The inventory position of 28 major pharmaceuticalmanufacturers in 2022 has been revealed in an annual report. It investigated how excessive inventories are affecting the industry and what factors could influence inventory growth in 2023. billion, representing a significant waste of capacity and resources.
Revised for 2023, the Parenteral Drug Association (PDA) has published an update to its Technical Report No. 43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for PharmaceuticalManufacturing.
billion and another 200 new jobs is planned for Eli Lilly and Company’s two new pharmaceuticalmanufacturing sites in Boone County, US. Eli Lilly’s investment here is the largest manufacturing investment at a single location in its history. Students will also be able to access a smart manufacturing lab.
Delpharm has acquired the Meppel pharmaceuticalmanufacturing facility in the Netherlands from Astellas. The acquisition will strengthen the CDMO’s position in the Netherlands, where it already owns a manufacturing facility in Bladel and an injectable drug development centre in Leiden. billion in 2024.
Innovations in the process spectroscopy market molecular spectroscopy accounted for the greatest share of the process spectroscopy market between 2023 to 2033″ The analysis found that molecular spectroscopy accounted for the greatest share of the process spectroscopy market between the 2023 to 2033 forecast period.
Novo Nordisk has announced plans to invest over 42 billion Danish kroner (nearly £5 billion) starting in 2023, to expand its manufacturing facilities in Kalundborg, Denmark. According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging.
The European Commission (EC)’s revised Annex 1 – Manufacture of Sterile Medicinal Products is now effective in the EU. As of 25 August 2023, pharmaceuticalmanufacturers are required to implement the GMP regulation into cleaning and bio-decontamination procedures for these products.
This step is important as these countries are key markets for pharmaceuticalsmanufacturing. Earlier in 2023, Task Force members launched joint, minimum environmental targets for suppliers. This requested that organisations set science-based targets beyond carbon emissions reductions, SMI continued.
Granules India Limited- Walk-In Interviews for Freshers On 16th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Granules India Limited- Walk-In Interviews for Freshers On 16th Feb’ 2023
The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceutical company filings.
SMS Pharmaceuticals Ltd- Walk-Ins for Accounts / Costing/ Finance On 8th Jan’ 2023. SMS Pharmaceuticals Ltd is one of the leading pharmaceuticalmanufacturing companies in India with world -class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO Standards.
The first industrial-scale pharmaceuticalmanufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. Radioligand therapy developments in 2023 and 2024 Other companies making progress producing radioligand therapies include Novartis. billion.
Advanced manufacturing “Advanced analytics leveraging AI/ML in the pharmaceuticalmanufacturing industry offers… possibilities [such as]… enhancing process control… and preventing batch losses.” On 2 May 2023, the FDA published draft guidance which included recommendations for delivering decentralised clinical trials.
Enhancing talent in pharmaceuticalmanufacturing “Talent and skills are fundamental to successful innovation and industry growth. This newly announced grant is part of the £650 million ‘Life Sci for Growth’ funding package launched in May 2023.
in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Furthermore, for months, several financial institutions such as Bank of America and JP Morgan have been talking of a “mild recession” in 2023 for the US. by the end of 2023 and may continue to rise in 2024 to 5%.
The global pharmaceutical industry experienced a 23% decline in the number of environmental sustainability-related patent applications in Q1 2023 compared with the previous quarter. The total number of environmental sustainability-related grants dropped by 24% in Q1 2023, according to GlobalData’s Patent Analytics. in Q1 2023.
Granules India Limited- Walk-In Drive for Capsule Filling / Warehouse/ QC On 17th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian.
Capitalising on the UK’s existing strengths by committing to a long-term manufacturing strategy, we will pave way for certainty, stability and sustained economic growth for businesses across our nation,” concluded Richard Torbett, ABPI’s Chief Executive.
The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.
Granules India Limited- Walk-In Drive for Compression/ Granulation/ Packing/ Engineering/ IPQA / QC/ Warehouse On 5th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian.
According to the BSI, all manufacturers of these products are eligible for the AMR certification to gain the BSI Kitemark , which involves an initial evaluation against the requirements of a designated international standard, published in June 2022.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content